Hematology
1832 CE — England, Thomas Hodgkin's published case series at Guy's Hospital
Hodgkin lymphoma entered the formal medical record in the nineteenth century when a British physician described a pattern of lymph node and spleen enlargement that distinguished it from other wasting diseases of the era. The condition's history is closely tied to the development of pathological anatomy and the gradual refinement of microscopic examination as a diagnostic tool. Over the following century, researchers debated its origins, classification, and nature with increasing precision as laboratory medicine transformed the study of blood and lymphatic diseases.
Historical Narrative
Before the nineteenth century, enlarged lymph nodes and the systemic deterioration associated with lymphatic disease were generally grouped under broad categories such as scrofula — a term historically applied to tuberculous lymphadenitis — or were simply absorbed into the undifferentiated mass of conditions causing cachexia and wasting. Ancient and medieval physicians recognized swollen glands as signs of illness but possessed no framework for distinguishing among what are now understood as separate diseases.
The decisive moment in the condition's medical history came in 1832, when Thomas Hodgkin, a pathologist and physician at Guy's Hospital in London, published a paper titled 'On Some Morbid Appearances of the Absorbent Glands and Spleen.' Drawing on post-mortem examinations of seven patients, Hodgkin described a progressive, fatal enlargement of lymph nodes and the spleen that he believed represented a primary disease of the lymphatic system rather than a secondary consequence of infection or inflammation. His paper received little immediate attention and was largely overlooked during his own lifetime.
It was Samuel Wilks, another Guy's Hospital physician, who rediscovered and amplified Hodgkin's original observations in 1856 and again in 1865. Wilks conducted his own series of autopsies and independently described the same pattern before encountering Hodgkin's earlier work. Recognizing his predecessor's priority, Wilks formally proposed the eponym 'Hodgkin's disease,' which became the standard designation for over a century.
Microscopic pathology proved essential to refining the disease's identity. In 1898 and 1902 respectively, Carl Sternberg in Vienna and Dorothy Reed in the United States independently described the large, distinctive binucleated giant cells found in affected lymph node tissue. These cells — subsequently named Reed-Sternberg cells — became the pathological hallmark used by later generations of physicians to confirm the diagnosis at autopsy and, eventually, through biopsy. Reed's meticulous microscopic work also helped clarify that the condition was distinct from tuberculosis, with which it had long been conflated due to overlapping clinical presentations.
Debate over whether the disease was infectious, inflammatory, or neoplastic persisted well into the twentieth century. Some researchers argued that the Reed-Sternberg cell was the product of an unusual inflammatory response, while others maintained it represented a malignant transformation. The infectious hypothesis attracted sustained attention, and various investigators attempted to link the condition to bacterial agents, fungi, and later viral candidates, though no consensus was reached during the early decades of investigation.
The classification of lymphatic diseases underwent repeated revision across the mid-twentieth century. Pathologists including Henry Rappaport and later Robert Lukes worked to subdivide Hodgkin's disease into histological subtypes based on the cellular composition of affected tissue, work that was formalized in international classification schemes. These taxonomic efforts reflected the broader transformation of hematology and oncology as laboratory disciplines, and positioned Hodgkin's disease as a central subject in the emerging science of lymphoma research throughout the twentieth century.
Key Historical Figures
Historical narrative only — this page describes how Hodgkin lymphoma was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.